Clinical Trial: RRX-001-211-01

Trial Status: Closed
Trial Types: NSCLC, Neuroedocrine, Ovarian, SCLC
Disease Type: Solid Tumors All
Trial ID RRX-001-211-01
Sponsor ID

A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Lung Cancer, EGFR TKI Resistant EGFR+ T790M Negative Non-Small Cell Lung Cancer, High Grade Neuroendocrine Tumors and Resistant/Refractory Ovarian Cancer Prior to Readministration of Platinum Based Doublet Regimens

Locations

Fairfax Office

Learn More About This Trial

Other Relevant Trials
Trial ID TSC-007
Sponsor ID PRECISION-1

A Phase 2 multi-center open-label basket trial of ABI-009 (nab-sirolimus) for adult and adolescent patients with solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes

Trial ID 516-014
Sponsor ID Mirati

A Multicenter, Open-Label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies